Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441408 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
While MM incidence rates were still increasing across SEE, mortality trends diverged and were less favourable than in NWE. Empowering cancer registration and improving the quality of incidence and mortality data will be essential for monitoring progress in MM control. In the context of prevention of melanoma, disparities in early detection appear to be widening the gap between SEE and NWE, while the provision of care to patients with advanced disease is likely to prove a challenge for regional healthcare budgets.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jelena Barbaric, Mario Sekerija, Dominic Agius, Daniela Coza, Nadya Dimitrova, Anna Demetriou, Chakameh Safaei Diba, Sultan Eser, Zivana Gavric, Maja Primic-Zakelj, Snezana Zivkovic, Miroslav Zvolsky, Freddie Bray, Jan Willem Coebergh, Ariana Znaor,